The Australian Pesticides and Veterinary Medicines Authority (APVMA) is considering an application for approval of the new active constituent posaconazole and registration of the product Mometamax Ultra Ear Drops Suspension for Dogs, containing 2.1 mg/mL mometasone furoate (as monohydrate), 2.6 mg/mL posaconazole, and 8.6 mg/mL gentamicin (as sulfate).

The Australian Pesticides and Veterinary Medicines Authority (APVMA) invites any person to submit a relevant written submission as to whether the application for a minor use permit for azoxystrobin, difenoconazole, fluopyram, isopyrazam and tebuconazole for use on plums should be granted. Submissions should relate only to matters that the APVMA is required by legislation to take into account in deciding whether to grant the application. These grounds relate to the trade implications of the extended use of the product. Submissions should state the grounds on which they are based.